Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0022575 (
keratoconjunctivitis sicca
)
772
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The PKR protein kinase is an important regulator of viral mRNA translation. A approximately 50-kb gene (Pkr) encodes the human PKR protein that is inducible by interferon (IFN). The Pkr promoter region has a novel 15-bp DNA element designated as
KCS
required for transcriptional activity that is located 4 bp upstream of a 13-bp IFN-stimulated response element (ISRE) that confers inducibility by type I IFN. We have carried out a systematic analysis of the 5' flanking region of the human Pkr gene to define how the novel
KCS
element acts to affect basal as well as IFN-inducible transcription. Electrophoretic mobility shift analyses (EMSA) revealed that nuclear proteins bound selectively to the
KCS
element in a manner that was not dependent upon either IFN treatment or protein binding at the adjacent ISRE element.
KCS
protein binding activity in vitro correlated with activation of transcription in vivo in transient transfection assays. Competitionsupershift EMSA assays revealed that multiple proteins were involved in bandshift complex formation with
KCS
, one of which was identified as factor
Sp1
. In addition to the positive regulatory domain containing the KCSISRE elements, a negative regulatory domain (NRD) was identified within a 40-bp region positioned approximately 400-bp upstream of the KCSISRE elements. Deletion and substitution mutations indicated that the NRD negatively affected Pkr transcription by a mechanism dependent upon the
KCS
element. These results define novel positivenegative regulatory domains within the Pkr promoter that function through the
KCS
element to affect basalIFN-inducible transcription of Pkr.
...
PMID:Mechanism of interferon action: functional characterization of positive and negative regulatory domains that modulate transcriptional activation of the human RNA-dependent protein kinase Pkr promoter. 992 85
The protein kinase regulated by RNA (PKR) is an important mediator of the antiviral and antiproliferative actions of interferon (IFN). The promoter of the PKR gene contains a novel 15-bp element designated
KCS
that is required for both basal and IFN-inducible transcription, with
KCS
function dependent upon both position and orientation relative to the ISRE element. Novel inducible protein complexes (iKIBP1, iKIBP2) that require both the
KCS
and the ISRE element sequences for their formation have been identified and characterized. Transcription factors
Sp1
and Sp3 were found to be
KCS
-binding proteins by electrophoretic mobility shift analyses (EMSA) and Sepharose bead-
KCS
oligonucleotide pull-down assays. However, only Sp3 but not
Sp1
was a constituent of the inducible iKIBP complexes. EMSA also identified STAT1, STAT2, and IRF-9 as components of the iKIBP complexes, indicating that ISGF-3 participates in iKIBP complex formation. Proteins bound at the
KCS
element in the absence of ISRE were able to recruit both STAT1 and STAT2 to the
KCS
element; recruitment was dependent upon IFN-alpha treatment. Chromatin immunoprecipitation assays revealed that the binding of Sp3, similar to STAT1 and STAT2, at the PKR promoter in vivo was IFN-dependent, but that
Sp1
binding was not dependent upon IFN treatment. These results, taken together, strongly suggest a role for
Sp1
in basal and Sp3 in inducible transcription of PKR and that a potential function of the
KCS
element is to facilitate the recruitment of ISGF-3 complex components to the PKR promoter to stimulate transcription.
...
PMID:The PKR kinase promoter binds both Sp1 and Sp3, but only Sp3 functions as part of the interferon-inducible complex with ISGF-3 proteins. 1295 21